{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T16:57:24Z","timestamp":1774976244972,"version":"3.50.1"},"reference-count":105,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07878-9","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T03:17:14Z","timestamp":1771989434000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Therapeutic potential of mesenchymal stem cells in ocular degenerative disorders"],"prefix":"10.1186","volume":"24","author":[{"given":"Yi","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guojin","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kangning","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1088-3647","authenticated-orcid":false,"given":"Yanni","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4418-4844","authenticated-orcid":false,"given":"Shizhou","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"7878_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1080\/14728222.2022.2030706","volume":"26","author":"AT Wolf","year":"2022","unstructured":"Wolf AT, Harris A, Oddone F, Siesky B, Verticchio Vercellin A, Ciulla TA. Disease progression pathways of wet AMD: opportunities for new target discovery. Expert Opin Ther Targets. 2022;26:5\u201312.","journal-title":"Expert Opin Ther Targets"},{"key":"7878_CR2","first-page":"225","volume":"117","author":"AK Schuster","year":"2020","unstructured":"Schuster AK, Erb C, Hoffmann EM, Dietlein T, Pfeiffer N. The diagnosis and treatment of glaucoma. Dtsch Arztebl Int. 2020;117:225\u201334.","journal-title":"Dtsch Arztebl Int"},{"key":"7878_CR3","doi-asserted-by":"crossref","first-page":"6979","DOI":"10.3390\/ijms25136979","volume":"25","author":"FJ Vizoso","year":"2024","unstructured":"Vizoso FJ, Costa LA, Eiro N. Mesenchymal stem cells and their derived products in ageing and diseases. Int J Mol Sci. 2024;25:6979.","journal-title":"Int J Mol Sci"},{"key":"7878_CR4","doi-asserted-by":"crossref","unstructured":"Yi W, Xue Y, Qing W, Cao Y, Zhou L, Xu M, et al. Effective treatment of optic neuropathies by intraocular delivery of MSC-sEVs through augmenting the G-CSF-macrophage pathway. Proc Natl Acad Sci U S A. 2024;121:e2305947121.","DOI":"10.1073\/pnas.2305947121"},{"key":"7878_CR5","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8:1605.","journal-title":"Cells"},{"key":"7878_CR6","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s13287-023-03287-7","volume":"14","author":"A Lotfy","year":"2023","unstructured":"Lotfy A, AboQuella NM, Wang H. Mesenchymal stromal\/stem cell (MSC)-derived exosomes in clinical trials. Stem Cell Res Ther. 2023;14:66.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR7","first-page":"267","volume":"4","author":"AJ Friedenstein","year":"1976","unstructured":"Friedenstein AJ, Gorskaja JF, Kulagina NN. Fibroblast precursors in normal and irradiated mouse hematopoietic organs. Exp Hematol. 1976;4:267\u201374.","journal-title":"Exp Hematol"},{"key":"7878_CR8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9:641\u201350.","journal-title":"J Orthop Res"},{"key":"7878_CR9","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1007\/s00018-019-03125-1","volume":"76","author":"A Naji","year":"2019","unstructured":"Naji A, Eitoku M, Favier B, Deschaseaux F, Rouas-Freiss N, Suganuma N. Biological functions of mesenchymal stem cells and clinical implications. Cell Mol Life Sci. 2019;76:3323\u201348.","journal-title":"Cell Mol Life Sci"},{"key":"7878_CR10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jconrel.2023.01.059","volume":"354","author":"K Malekpour","year":"2023","unstructured":"Malekpour K, Hazrati A, Soudi S, Hashemi SM. Mechanisms behind therapeutic potentials of mesenchymal stem cell mitochondria transfer\/delivery. J Control Release. 2023;354:755\u201369.","journal-title":"J Control Release"},{"key":"7878_CR11","doi-asserted-by":"crossref","unstructured":"Maacha S, Sidahmed H, Jacob S, Gentilcore G, Calzone R, Grivel J-C, et al. Paracrine Mechanisms of mesenchymal stromal cells in angiogenesis. Stem Cells Int. 2020, 2020: 1\u201312.","DOI":"10.1155\/2020\/4356359"},{"key":"7878_CR12","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1089\/cell.2018.0045","volume":"20","author":"A Oner","year":"2018","unstructured":"Oner A, Gonen ZB, Sevim DG, Smim Kahraman N, Unlu M. Suprachoroidal adipose tissue-derived mesenchymal stem cell implantation in patients with dry-type age-related macular degeneration and Stargardt\u2019s macular dystrophy: 6-month follow-up results of a phase 2 study. Cell Reprogram. 2018;20:329\u201336.","journal-title":"Cell Reprogram"},{"key":"7878_CR13","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1517\/14712598.2015.997706","volume":"15","author":"A Del Fattore","year":"2015","unstructured":"Del Fattore A, Luciano R, Saracino R, Battafarano G, Rizzo C, Pascucci L, et al. Differential effects of extracellular vesicles secreted by mesenchymal stem cells from different sources on glioblastoma cells. Expert Opin Biol Ther. 2015;15:495\u2013504.","journal-title":"Expert Opin Biol Ther"},{"key":"7878_CR14","doi-asserted-by":"crossref","first-page":"120570","DOI":"10.1016\/j.lfs.2022.120570","volume":"300","author":"AR Dezfuly","year":"2022","unstructured":"Dezfuly AR, Safaee A, Amirpour N, Kazemi M, Ramezani A, Jafarinia M, et al. Therapeutic effects of human adipose mesenchymal stem cells and their paracrine agents on sodium iodate induced retinal degeneration in rats. Life Sci. 2022;300:120570.","journal-title":"Life Sci"},{"key":"7878_CR15","doi-asserted-by":"crossref","first-page":"7742","DOI":"10.1523\/JNEUROSCI.23-21-07742.2003","volume":"23","author":"A Kicic","year":"2003","unstructured":"Kicic A, Shen W-Y, Wilson AS, Constable IJ, Robertson T, Rakoczy PE. Differentiation of marrow stromal cells into photoreceptors in the rat eye. J Neurosci. 2003;23:7742\u201349.","journal-title":"J Neurosci"},{"key":"7878_CR16","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1590\/S0004-27492008000500007","volume":"71","author":"P Castanheira","year":"2008","unstructured":"Castanheira P, Torquetti L, Nehemy MB, Goes AM. Retinal incorporation and differentiation of mesenchymal stem cells intravitreally injected in the injured retina of rats. Arq Bras Oftalmol. 2008;71:644\u201350.","journal-title":"Arq Bras Oftalmol"},{"key":"7878_CR17","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1177\/0963689717721227","volume":"26","author":"V Holan","year":"2017","unstructured":"Holan V, Hermankova B, Kossl J. Perspectives of stem cell-based therapy for age-related retinal degenerative diseases. Cell Transpl. 2017;26:1538\u201341.","journal-title":"Cell Transpl"},{"key":"7878_CR18","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12886-021-02171-3","volume":"22","author":"Q Liang","year":"2022","unstructured":"Liang Q, Li Q, Ren B, Yin ZQ. Intravenous infusion of small umbilical cord mesenchymal stem cells could enhance safety and delay retinal degeneration in RCS rats. BMC Ophthalmol. 2022;22:67.","journal-title":"BMC Ophthalmol"},{"key":"7878_CR19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s13287-022-03100-x","volume":"13","author":"J Zhang","year":"2022","unstructured":"Zhang J, Li P, Zhao G, He S, Xu D, Jiang W, et al. Mesenchymal stem cell-derived extracellular vesicles protect retina in a mouse model of retinitis pigmentosa by anti-inflammation through miR-146a-Nr4a3 axis. STEM Cell Res Ther. 2022;13:394.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR20","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s13287-022-02828-w","volume":"13","author":"C Brown","year":"2022","unstructured":"Brown C, Agosta P, McKee C, Walker K, Mazzella M, Alamri A, et al. Human primitive mesenchymal stem cell-derived retinal progenitor cells improved neuroprotection, neurogenesis, and vision in rd12 mouse model of retinitis pigmentosa. STEM Cell Res Ther. 2022;13:148.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR21","doi-asserted-by":"crossref","unstructured":"Di Pierdomenico J, Gallego-Ortega A, Mart\u00ednez-Vacas, Garc\u00eda-Bernal, Vidal-Sanz M, Villegas-P\u00e9rez, et al. Intravitreal and subretinal syngeneic bone marrow mononuclear stem cell transplantation improves photoreceptor survival but does not ameliorate retinal function in two rat models of retinal degeneration. Acta Ophthalmol. 2022;100:e1313\u201331.","DOI":"10.1111\/aos.15165"},{"key":"7878_CR22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13287-015-0020-6","volume":"6","author":"RC Siqueira","year":"2015","unstructured":"Siqueira RC, Messias A, Messias K, Arcieri RS, Ruiz MA, Souza NF, et al. Quality of life in patients with retinitis pigmentosa submitted to intravitreal use of bone marrow-derived stem cells (reticell -clinical trial). STEM Cell Res Ther. 2015;6:29.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR23","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1097\/IAE.0b013e3181f9c242","volume":"31","author":"RC Siqueira","year":"2011","unstructured":"Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal injection of autologous bone marrow-derived mononuclear cells for hereditary retinal dystrophy: a phase I trial. Retina. 2011;31:1207\u201314.","journal-title":"Retina"},{"key":"7878_CR24","doi-asserted-by":"crossref","first-page":"58","DOI":"10.4103\/2008-322X.200164","volume":"12","author":"L Satarian","year":"2017","unstructured":"Satarian L, Nourinia R, Safi S, Kanavi M, Jarughi N, Daftarian N, et al. Intravitreal injection of bone marrow mesenchymal stem cells in patients with advanced retinitis pigmentosa; a safety study. J Ophthalmic Vis Res. 2017;12:58.","journal-title":"J Ophthalmic Vis Res"},{"key":"7878_CR25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s13287-020-02122-7","volume":"12","author":"A Tuekprakhon","year":"2021","unstructured":"Tuekprakhon A, Sangkitporn S, Trinavarat A, Pawestri AR, Vamvanij V, Ruangchainikom M, et al. Intravitreal autologous mesenchymal stem cell transplantation: a non-randomized phase I clinical trial in patients with retinitis pigmentosa. STEM Cell Res Ther. 2021;12:52.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR26","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s13287-023-03489-z","volume":"14","author":"B \u00d6zkan","year":"2023","unstructured":"\u00d6zkan B, Y\u0131lmaz Tu\u011fan B, Hem\u015finlio\u011flu C, S\u0131r Karaku\u015f G, \u015eahin \u00d6, Oval\u0131 E. Suprachoroidal spheroidal mesenchymal stem cell implantation in retinitis pigmentosa: clinical results of 6 months follow-up. STEM Cell Res Ther. 2023;14:252.","journal-title":"STEM Cell Res Ther"},{"key":"7878_CR27","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/stcltm\/szad051","volume":"12","author":"E Ozmert","year":"2023","unstructured":"Ozmert E, Arslan U. Management of retinitis pigmentosa via Wharton\u2019s jelly-derived mesenchymal stem cells or combination with magnovision: 3-year prospective results. STEM Cells Transl Med. 2023;12:631\u201350.","journal-title":"STEM Cells Transl Med"},{"key":"7878_CR28","unstructured":"Mahabadi N, Al Khalili Y. Neuroanatomy, retina. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Jul 28]. Available from:http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK545310\/."},{"key":"7878_CR29","doi-asserted-by":"crossref","first-page":"5977","DOI":"10.1007\/s00018-021-03893-9","volume":"78","author":"L Ji","year":"2021","unstructured":"Ji L, Tian H, Webster KA, Li W. Neurovascular regulation in diabetic retinopathy and emerging therapies. Cell Mol Life Sci. 2021;78:5977\u201385.","journal-title":"Cell Mol Life Sci"},{"key":"7878_CR30","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cub.2024.11.023","volume":"35","author":"WN Grimes","year":"2025","unstructured":"Grimes WN, Berson DM, Sabnis A, Hoon M, Sinha R, Tian H, et al. Layer-specific anatomical and physiological features of the retina\u2019s neurovascular unit. Curr Biol. 2025;35:109\u201320.e4.","journal-title":"Curr Biol"},{"key":"7878_CR31","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/s41574-020-00451-4","volume":"17","author":"DA Antonetti","year":"2021","unstructured":"Antonetti DA, Silva PS, Stitt AW. Current understanding of the molecular and cellular pathology of diabetic retinopathy. Nat Rev Endocrinol. 2021;17:195\u2013206.","journal-title":"Nat Rev Endocrinol"},{"key":"7878_CR32","doi-asserted-by":"crossref","first-page":"114829","DOI":"10.1016\/j.ejmech.2022.114829","volume":"244","author":"M Wang","year":"2022","unstructured":"Wang M, Sheng K-J, Fang J-C, Zhao H, Lu S-M, Liu Z-Y, et al. Redox signaling in diabetic retinopathy and opportunity for therapeutic intervention through natural products. Eur J Med Chem. 2022;244:114829.","journal-title":"Eur J Med Chem"},{"key":"7878_CR33","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/db14-0016","volume":"64","author":"H Huang","year":"2015","unstructured":"Huang H, He J, Johnson D, Wei Y, Liu Y, Wang S, et al. Deletion of placental growth factor prevents diabetic retinopathy and is associated with Akt activation and HIF1\u03b1-VEGF pathway inhibition. diabetes. 2015;64:200\u201312. Diabetes. 2015, 64: 1067.","journal-title":"diabetes"},{"key":"7878_CR34","first-page":"444","volume":"33","author":"F Sun","year":"2024","unstructured":"Sun F, Sun Y, Wang X, Zhu J, Chen S, Yu Y, et al. Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1\u03b1\/EZH2\/PGC-1\u03b1 pathway. Bioact Mater. 2024;33:444\u201359.","journal-title":"Bioact Mater"},{"key":"7878_CR35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.biopha.2018.06.129","volume":"106","author":"T Xu","year":"2018","unstructured":"Xu T, Lv Z, Chen Q, Guo M, Wang X, Huang F. Vascular endothelial growth factor over-expressed mesenchymal stem cells-conditioned media ameliorate palmitate-induced diabetic endothelial dysfunction through PI-3K\/AKT\/m-TOR\/eNOS and p38\/MAPK signaling pathway. Biomed Pharmacother. 2018;106:491\u201398.","journal-title":"Biomed Pharmacother"},{"key":"7878_CR36","doi-asserted-by":"crossref","unstructured":"Liu J, Hao H, Xia L, Ti D, Huang H, Dong L, et al. Hypoxia pretreatment of bone marrow mesenchymal stem cells facilitates angiogenesis by improving the function of endothelial cells in diabetic rats with lower ischemia. PLoS One. 2015;10:e0126715.","DOI":"10.1371\/journal.pone.0126715"},{"key":"7878_CR37","doi-asserted-by":"crossref","unstructured":"Zhang W, Wang Y, Kong Y. Exosomes derived from mesenchymal stem cells modulate miR-126 to ameliorate hyperglycemia-induced retinal inflammation via targeting HMGB1. Invest Ophthalmol Visual Sci [Internet]. 2019 [cited 2025 Mar 4];60. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30657854\/.","DOI":"10.1167\/iovs.18-25617"},{"key":"7878_CR38","doi-asserted-by":"crossref","first-page":"107010","DOI":"10.1016\/j.intimp.2020.107010","volume":"90","author":"W Li","year":"2021","unstructured":"Li W, Jin L-Y, Cui Y-B, Xie N. Human umbilical cord mesenchymal stem cells-derived exosomal microRNA-17-3p ameliorates inflammatory reaction and antioxidant injury of mice with diabetic retinopathy via targeting STAT1. Int Immunopharmacol. 2021;90:107010.","journal-title":"Int Immunopharmacol"},{"key":"7878_CR39","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1002\/jcp.30213","volume":"236","author":"C Gu","year":"2021","unstructured":"Gu C, Zhang H, Gao Y. Adipose mesenchymal stem cells-secreted extracellular vesicles containing microRNA-192 delays diabetic retinopathy by targeting ITGA1. J Cell Physiol. 2021;236:5036\u201351.","journal-title":"J Cell Physiol"},{"key":"7878_CR40","doi-asserted-by":"crossref","unstructured":"Liang G, Qin Z, Luo Y, Yin J, Shi Z, Wei R, et al. Exosomal microRNA-133b-3p from bone marrow mesenchymal stem cells inhibits angiogenesis and oxidative stress via FBN1 repression in diabetic retinopathy. Gene Ther [Internet]. 2022 [cited 2025 Mar 4];29. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35125496\/.","DOI":"10.1038\/s41434-021-00310-5"},{"key":"7878_CR41","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.18240\/ijo.2021.08.19","volume":"14","author":"Z-Y Cai","year":"2021","unstructured":"Cai Z-Y, Fu M-D, Liu K, Duan X-C. Therapeutic effect of Keap1-Nrf2-ARE pathway-related drugs on age-related eye diseases through anti-oxidative stress. Int J Ophthalmol. 2021;14:1260\u201373.","journal-title":"Int J Ophthalmol"},{"key":"7878_CR42","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1007\/s10753-024-02005-6","volume":"47","author":"J Tong","year":"2024","unstructured":"Tong J, Yao G, Chen Y, Xie H, Zheng X, Sun L, et al. Mesenchymal stem cells regulate microglial polarization via inhibition of the HMGB1\/TLR4 signaling pathway in diabetic retinopathy. Inflammation. 2024;47:1728\u201343.","journal-title":"Inflammation"},{"key":"7878_CR43","doi-asserted-by":"crossref","unstructured":"Xu Z, Tian N, Li S, Li K, Guo H, Zhang H, et al. Extracellular vesicles secreted from mesenchymal stem cells exert anti-apoptotic and anti-inflammatory effects via transmitting microRNA-18b in rats with diabetic retinopathy. International immunopharmacology [Internet]. 2021 [cited 2025 Mar 4];101. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/34655847\/.","DOI":"10.1016\/j.intimp.2021.108234"},{"key":"7878_CR44","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1161\/ATVBAHA.110.206201","volume":"30","author":"P Dentelli","year":"2010","unstructured":"Dentelli P, Rosso A, Orso F, Olgasi C, Taverna D, Brizzi MF. microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression. Arterioscler Thromb Vasc Biol. 2010;30:1562\u201368.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"7878_CR45","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1093\/stmcls\/sxad078","volume":"42","author":"Y Chen","year":"2024","unstructured":"Chen Y, Yao G, Tong J, Xie H, Zheng X, Zhang H, et al. MSC-Derived small extracellular vesicles alleviate diabetic retinopathy by delivering miR-22-3p to inhibit NLRP3 inflammasome activation. STEM Cells. 2024;42:64\u201375.","journal-title":"STEM Cells"},{"key":"7878_CR46","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1186\/s12974-022-02562-3","volume":"19","author":"A Rajesh","year":"2022","unstructured":"Rajesh A, Droho S, Lavine JA. Macrophages in close proximity to the vitreoretinal interface are potential biomarkers of inflammation during retinal vascular disease. J Neuroinflammation. 2022;19:203.","journal-title":"J Neuroinflammation"},{"key":"7878_CR47","doi-asserted-by":"crossref","unstructured":"Li W, Jin L, Cui Y, Nie A, Xie N, Liang G. Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4\/NF-\u03baB axis repression. J Endocrinological Investigation [Internet]. 2021 [cited 2025 Mar 4];44. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/32979189\/.","DOI":"10.1007\/s40618-020-01405-3"},{"key":"7878_CR48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","volume":"19","author":"S Herzig","year":"2018","unstructured":"Herzig S, Shaw RJ. AMPK: guardian of metabolism and mitochondrial homeostasis. Nat Rev Mol Cell Biol. 2018;19:121\u201335.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"7878_CR49","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1042\/CS20160235","volume":"130","author":"Y Yuan","year":"2016","unstructured":"Yuan Y, Shi M, Li L, Liu J, Chen B, Chen Y, et al. Mesenchymal stem cell-conditioned media ameliorate diabetic endothelial dysfunction by improving mitochondrial bioenergetics via the Sirt1\/AMPK\/PGC-1\u03b1 pathway. Clin Sci (Lond). 2016;130:2181\u201398.","journal-title":"Clin Sci (Lond)"},{"key":"7878_CR50","doi-asserted-by":"crossref","unstructured":"Liu Y, Chen J, Liang H, Cai Y, Li X, Yan L, et al. Human umbilical cord-derived mesenchymal stem cells not only ameliorate blood glucose but also protect vascular endothelium from diabetic damage through a paracrine mechanism mediated by MAPK\/ERK signaling. STEM Cell Res Ther [Internet]. 2022 [cited 2025 Mar 24];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35715841\/.","DOI":"10.1186\/s13287-022-02927-8"},{"key":"7878_CR51","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/biomedicines9070791","volume":"9","author":"S-M Park","year":"2021","unstructured":"Park S-M, Kang T-I, So J-S. Roles of XBP1s in transcriptional regulation of target genes. Biomedicines. 2021;9:791.","journal-title":"Biomedicines"},{"key":"7878_CR52","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.18240\/ijo.2021.11.06","volume":"14","author":"X Gao","year":"2021","unstructured":"Gao X, He G-H, Zhang X-T, Chen S. Protective effect of human umbilical cord mesenchymal stem cell-derived exosomes on rat retinal neurons in hyperglycemia through the brain-derived neurotrophic factor\/TrkB pathway. Int J Ophthalmol. 2021;14:1683\u201389.","journal-title":"Int J Ophthalmol"},{"key":"7878_CR53","doi-asserted-by":"crossref","first-page":"109015","DOI":"10.1016\/j.exer.2022.109015","volume":"218","author":"L Huang","year":"2022","unstructured":"Huang L, Yao T, Chen J, Zhang Z, Yang W, Gao X, et al. Effect of Sirt3 on retinal pigment epithelial cells in high glucose through Foxo3a\/PINK1-parkin pathway mediated mitophagy. Exp Eye Res. 2022;218:109015.","journal-title":"Exp Eye Res"},{"key":"7878_CR54","doi-asserted-by":"crossref","unstructured":"Sun F, Sun Y, Zhu J, Wang X, Ji C, Zhang J, et al. Mesenchymal stem cells-derived small extracellular vesicles alleviate diabetic retinopathy by delivering NEDD4. STEM Cell Res Ther [Internet]. 2022 [cited 2025 Mar 4];13. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/35841055\/.","DOI":"10.1186\/s13287-022-02983-0"},{"key":"7878_CR55","doi-asserted-by":"crossref","unstructured":"Yu H, Zhong H, Li N, Chen K, Chen J, Sun J, et al. Osteopontin activates retinal microglia causing retinal ganglion cells loss via p38 MAPK signaling pathway in glaucoma. Faseb J [Internet]. 2021 [cited 2025 May 12];35. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1096\/fj.202002218R.","DOI":"10.1096\/fj.202002218R"},{"key":"7878_CR56","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.exer.2018.03.006","volume":"171","author":"de Hoz R","year":"2018","unstructured":"de Hoz R, Ram\u00edrez, R G-M, Ajoy D, Rojas B, Salobrar-Garcia E, et al. Bilateral early activation of retinal microglial cells in a mouse model of unilateral laser-induced experimental ocular hypertension. Exp Eye Res. 2018;171:12\u201329.","journal-title":"Exp Eye Res"},{"key":"7878_CR57","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1186\/s12974-020-02012-y","volume":"17","author":"P Grotegut","year":"2020","unstructured":"Grotegut P, Perumal N, Kuehn S, Smit A, Dick HB, Grus FH, et al. Minocycline reduces inflammatory response and cell death in a S100B retina degeneration model. J Neuroinflammation. 2020;17:375.","journal-title":"J Neuroinflammation"},{"key":"7878_CR58","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/jmcb\/mjx022","volume":"9","author":"W Su","year":"2017","unstructured":"Su W, Li Z, Jia Y, Zhu Y, Cai W, Wan P, et al. microRNA-21a-5p\/PDCD4 axis regulates mesenchymal stem cell-induced neuroprotection in acute glaucoma. J Mol Cell Biol. 2017;9:289\u2013301.","journal-title":"J Mol Cell Biol"},{"key":"7878_CR59","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1002\/sctm.16-0428","volume":"6","author":"B Mead","year":"2017","unstructured":"Mead B, Tomarev S. Bone marrow-derived mesenchymal stem cells-derived exosomes promote survival of retinal ganglion cells through miRNA-Dependent Mechanisms. STEM Cells Transl Med. 2017;6:1273\u201385.","journal-title":"STEM Cells Transl Med"},{"key":"7878_CR60","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.biomaterials.2019.01.016","volume":"197","author":"B Mathew","year":"2019","unstructured":"Mathew B, Ravindran S, Liu X, Torres L, Chennakesavalu M, Huang C-C, et al. Mesenchymal stem cell-derived extracellular vesicles and retinal ischemia-reperfusion. Biomaterials. 2019;197:146\u201360.","journal-title":"Biomaterials"},{"key":"7878_CR61","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40478-024-01753-8","volume":"12","author":"S Ji","year":"2024","unstructured":"Ji S, Peng Y, Liu J, Xu P, Tang S. Human adipose tissue-derived stem cell extracellular vesicles attenuate ocular hypertension-induced retinal ganglion cell damage by inhibiting microglia- TLR4\/MAPK\/NF-\u03baB proinflammatory cascade signaling. Acta Neuropathol Commun. 2024;12:44.","journal-title":"Acta Neuropathol Commun"},{"key":"7878_CR62","doi-asserted-by":"crossref","unstructured":"Ali MU, Rahman MSU, Cao J, Yuan PX. Genetic characterization and disease mechanism of retinitis pigmentosa; current scenario. 3 biotech. 2017. 7:251.","DOI":"10.1007\/s13205-017-0878-3"},{"key":"7878_CR63","doi-asserted-by":"crossref","first-page":"588","DOI":"10.3390\/cells10030588","volume":"10","author":"V Holan","year":"2021","unstructured":"Holan V, Palacka K, Hermankova B. Mesenchymal stem cell-based therapy for retinal degenerative diseases: experimental models and clinical trials. Cells. 2021;10:588.","journal-title":"Cells"},{"key":"7878_CR64","doi-asserted-by":"crossref","unstructured":"Mahmoudian-Sani M-R, Forouzanfar F, Asgharzade S, Ghorbani N. Overexpression of MiR-183\/96\/182 Triggers retina-like fate in human bone marrow-derived mesenchymal stem cells (hBmscs) in culture. J Ophthalmol. 2019, 2019: 2454362.","DOI":"10.1155\/2019\/2454362"},{"key":"7878_CR65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.omtn.2019.11.005","volume":"19","author":"M Karali","year":"2020","unstructured":"Karali M, Guadagnino I, Marrocco E, De Cegli R, Carissimo A, Pizzo M, et al. AAV-miR-204 protects from retinal degeneration by attenuation of microglia activation and photoreceptor cell death. Mol Ther - Nucleic Acids. 2020;19:144\u201356.","journal-title":"Mol Ther - Nucleic Acids"},{"key":"7878_CR66","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1001\/jama.2023.26074","volume":"331","author":"M Fleckenstein","year":"2024","unstructured":"Fleckenstein M, Schmitz-Valckenberg S, Chakravarthy U. Age-related macular degeneration: a review. JAMA. 2024;331:147\u201357.","journal-title":"JAMA"},{"key":"7878_CR67","doi-asserted-by":"crossref","unstructured":"Yu B, Wang K, Hao H, Liu Y, Yue Y, Li X, et al. Small extracellular vesicles derived from microRNA-22-3p-overexpressing mesenchymal stem cells protect retinal ganglion cells by regulating MAPK pathway. Commun Biol [Internet]. 2024 [cited 2025 Mar 5];7. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/38961177\/.","DOI":"10.1038\/s42003-024-06511-z"},{"key":"7878_CR68","doi-asserted-by":"crossref","first-page":"100858","DOI":"10.1016\/j.preteyeres.2020.100858","volume":"79","author":"K Kaarniranta","year":"2020","unstructured":"Kaarniranta K, Uusitalo H, Blasiak J, Felszeghy S, Kannan R, Kauppinen A, et al. Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res. 2020;79:100858.","journal-title":"Prog Retin Eye Res"},{"key":"7878_CR69","doi-asserted-by":"crossref","unstructured":"Felszeghy S, Viiri J, Paterno JJ, Hyttinen JMT, Koskela A, Chen M, et al. Loss of NRF-2 and PGC-1\u03b1 genes leads to retinal pigment epithelium damage resembling dry age-related macular degeneration. Redox Biol [Internet]. 2019 [cited 2025 Mar 25];20. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/30253279\/.","DOI":"10.1016\/j.redox.2018.09.011"},{"key":"7878_CR70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jconrel.2023.04.003","volume":"357","author":"Y Tang","year":"2023","unstructured":"Tang Y, Kang Y, Zhang X, Cheng C. Mesenchymal stem cell exosomes as nanotherapeutics for dry age-related macular degeneration. J Control Release. 2023;357:356\u201370.","journal-title":"J Control Release"},{"key":"7878_CR71","doi-asserted-by":"crossref","unstructured":"Mao X, Pan T, Shen H, Xi H, Yuan S, Liu Q. The rescue effect of mesenchymal stem cell on sodium iodate-induced retinal pigment epithelial cell death through deactivation of NF-\u03baB-mediated NLRP3 inflammasome. Biomedicine & pharmacotherapy = biomedecine & pharmacotherapie [Internet]. 2018 [cited 2025 Mar 6];103. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29677537\/.","DOI":"10.1016\/j.biopha.2018.04.038"},{"key":"7878_CR72","doi-asserted-by":"crossref","first-page":"160","DOI":"10.3389\/fncel.2020.00160","volume":"14","author":"Y Wooff","year":"2020","unstructured":"Wooff Y, Cioanca AV, Chu-Tan JA, Aggio-Bruce R, Schumann U, Natoli R. Small-medium extracellular vesicles and their miRNA cargo in retinal health and degeneration: mediators of homeostasis, and vehicles for targeted gene therapy. Front Cell Neurosci. 2020;14:160.","journal-title":"Front Cell Neurosci"},{"key":"7878_CR73","doi-asserted-by":"crossref","unstructured":"Chichagova V, Hallam D, Collin J, Zerti D, Dorgau B, Felemban M, et al. Cellular regeneration strategies for macular degeneration: past, present and future. Eye (London, England) [Internet]. 2018 [cited 2025 Mar 5];32. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/29503449\/.","DOI":"10.1038\/s41433-018-0061-z"},{"key":"7878_CR74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13816810.2021.1966053","volume":"43","author":"D Huang","year":"2022","unstructured":"Huang D, Heath Jeffery RC, Aung-Htut MT, McLenachan S, Fletcher S, Wilton SD, et al. Stargardt disease and progress in therapeutic strategies. Ophthalmic Genet. 2022;43:1\u201326.","journal-title":"Ophthalmic Genet"},{"key":"7878_CR75","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.3390\/genes14081659","volume":"14","author":"S Zampatti","year":"2023","unstructured":"Zampatti S, Peconi C, Calvino G, Ferese R, Gambardella S, Cascella R, et al. A splicing variant in RDH8 is associated with autosomal recessive Stargardt macular dystrophy. Genes (Basel). 2023;14:1659.","journal-title":"Genes (Basel)"},{"key":"7878_CR76","first-page":"10","volume":"8","author":"JN Weiss","year":"2021","unstructured":"Weiss JN, Levy S. Stem cell ophthalmology treatment study (SCOTS): Bone marrow-derived stem cells in the treatment of Stargardt disease. Med (Basel). 2021;8:10.","journal-title":"Med (Basel)"},{"key":"7878_CR77","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.colsurfb.2018.12.063","volume":"176","author":"MJ Feito","year":"2019","unstructured":"Feito MJ, Diez-Orejas R, Cicu\u00e9ndez M, Casarrubios L, Rojo JM, Portol\u00e9s MT. Characterization of M1 and M2 polarization phenotypes in peritoneal macrophages after treatment with graphene oxide nanosheets. Colloids Surfaces B: Biointerfaces. 2019;176:96\u2013105.","journal-title":"Colloids Surfaces B: Biointerfaces"},{"key":"7878_CR78","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12031-020-01674-w","volume":"71","author":"N Wagner","year":"2021","unstructured":"Wagner N, Reinehr S, Palmhof M, Schuschel D, Tsai T, Sommer E, et al. Microglia activation in retinal ischemia Triggers cytokine and Toll-like receptor response. J Mol Neurosci. 2021;71:527\u201344.","journal-title":"J Mol Neurosci"},{"key":"7878_CR79","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1016\/j.cell.2021.06.031","volume":"184","author":"X Guo","year":"2021","unstructured":"Guo X, Zhou J, Starr C, Mohns EJ, Li Y, Chen E, et al. Preservation of vision after CaMKII-mediated protection of retinal ganglion cells. Cell. 2021;184:4299\u2013314.e12.","journal-title":"Cell"},{"key":"7878_CR80","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1080\/02713683.2017.1319491","volume":"42","author":"E Moisseiev","year":"2017","unstructured":"Moisseiev E, Anderson JD, Oltjen S, Goswami M, Zawadzki RJ, Nolta JA, et al. Protective effect of Intravitreal administration of exosomes derived from mesenchymal stem cells on retinal ischemia. Curr Eye Res. 2017;42:1358\u201367.","journal-title":"Curr Eye Res"},{"key":"7878_CR81","doi-asserted-by":"crossref","unstructured":"Yu B, Shao H, Su C, Jiang Y, Chen X, Bai L, et al. Exosomes derived from MSCs ameliorate retinal laser injury partially by inhibition of MCP-1. Sci Rep [Internet]. 2016 [cited 2025 Mar 5];6. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/27686625\/.","DOI":"10.1038\/srep34562"},{"key":"7878_CR82","doi-asserted-by":"crossref","first-page":"107598","DOI":"10.1016\/j.intimp.2021.107598","volume":"101","author":"S Singh","year":"2021","unstructured":"Singh S, Anshita D, Ravichandiran V. MCP-1: function, regulation, and involvement in disease. Int Immunopharmacol. 2021;101:107598.","journal-title":"Int Immunopharmacol"},{"key":"7878_CR83","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.3390\/cells10113006","volume":"10","author":"M Agrawal","year":"2021","unstructured":"Agrawal M, Rasiah PK, Bajwa A, Rajasingh J, Gangaraju R. Mesenchymal stem cell induced Foxp3(+) Tregs suppress effector T cells and protect against retinal ischemic injury. Cells. 2021;10:3006.","journal-title":"Cells"},{"key":"7878_CR84","doi-asserted-by":"crossref","first-page":"586487","DOI":"10.3389\/fcell.2020.586487","volume":"8","author":"W Zhou","year":"2020","unstructured":"Zhou W, Lin D, Zhong Z, Ye Q. Roles of TRAFs in ischemia-reperfusion injury. Front Cell Dev Biol. 2020;8:586487.","journal-title":"Front Cell Dev Biol"},{"key":"7878_CR85","doi-asserted-by":"crossref","unstructured":"He C, Liu Y, Huang Z, Yang Z, Zhou T, Liu S, et al. A specific RIP3+ subpopulation of microglia promotes retinopathy through a hypoxia-triggered necroptotic mechanism. Proc Natl Acad Sci U S A. 2021;118:e2023290118.","DOI":"10.1073\/pnas.2023290118"},{"key":"7878_CR86","doi-asserted-by":"crossref","first-page":"121484","DOI":"10.1016\/j.biomaterials.2022.121484","volume":"284","author":"Z Yu","year":"2022","unstructured":"Yu Z, Wen Y, Jiang N, Li Z, Guan J, Zhang Y, et al. TNF-\u03b1 stimulation enhances the neuroprotective effects of gingival MSCs derived exosomes in retinal ischemia-reperfusion injury via the MEG3\/miR-21a-5p axis. Biomaterials. 2022;284:121484.","journal-title":"Biomaterials"},{"key":"7878_CR87","doi-asserted-by":"crossref","unstructured":"Ma M, Li B, Zhang M, Zhou L, Yang F, Ma F, et al. Therapeutic effects of mesenchymal stem cell-derived exosomes on retinal detachment. Exp Eye Res [Internet]. 2020 [cited 2025 Mar 5];191. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31866431\/.","DOI":"10.1016\/j.exer.2019.107899"},{"key":"7878_CR88","doi-asserted-by":"crossref","unstructured":"Li L, Du G, Wang D, Zhou J, Jiang G, Jiang H. Overexpression of heme oxygenase-1 in mesenchymal stem cells augments their protection on retinal cells in vitro and attenuates retinal Ischemia\/Reperfusion injury in vivo against oxidative stress. Stem Cells Int. 2017, 2017: 4985323.","DOI":"10.1155\/2017\/4985323"},{"key":"7878_CR89","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.3390\/ijms22042117","volume":"22","author":"Y-T Wen","year":"2021","unstructured":"Wen Y-T, Ho Y-C, Lee Y-C, Ding D-C, Liu P-K, Tsai R-K. The benefits and hazards of Intravitreal mesenchymal stem cell (MSC) based-therapies in the experimental ischemic optic neuropathy. Int J Mol Sci. 2021;22:2117.","journal-title":"Int J Mol Sci"},{"key":"7878_CR90","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1007\/s12015-020-10090-x","volume":"17","author":"S Adak","year":"2021","unstructured":"Adak S, Magdalene D, Deshmukh S, Das D, Jaganathan BG. A review on mesenchymal stem cells for treatment of retinal diseases. Stem Cell Rev Rep. 2021;17:1154\u201373.","journal-title":"STEM Cell Rev Rep"},{"key":"7878_CR91","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1080\/02713683.2018.1440604","volume":"43","author":"S Ji","year":"2018","unstructured":"Ji S, Lin S, Chen J, Huang X, Wei C-C, Li Z, et al. Neuroprotection of transplanting human umbilical cord mesenchymal stem cells in a microbead induced ocular hypertension rat model. Curr Eye Res. 2018;43:810\u201320.","journal-title":"Curr Eye Res"},{"key":"7878_CR92","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1159\/000512469","volume":"64","author":"J Li","year":"2021","unstructured":"Li J, Bai X, Guan X, Yuan H, Xu X. Treatment of optic canal decompression combined with umbilical cord mesenchymal stem (stromal) cells for indirect traumatic optic neuropathy: a phase 1 clinical trial. Ophthalmic Res. 2021;64:398\u2013404.","journal-title":"Ophthalmic Res"},{"key":"7878_CR93","doi-asserted-by":"crossref","first-page":"26463","DOI":"10.1038\/srep26463","volume":"6","author":"OW Gramlich","year":"2016","unstructured":"Gramlich OW, Burand AJ, Brown AJ, Deutsch RJ, Kuehn MH, Ankrum JA. Cryopreserved mesenchymal stromal cells maintain potency in a retinal Ischemia\/Reperfusion injury model: toward an off-the-shelf therapy. Sci Rep. 2016;6:26463.","journal-title":"Sci Rep"},{"key":"7878_CR94","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1097\/IAE.0000000000003163","volume":"41","author":"RN Louzada","year":"2021","unstructured":"Louzada RN, Ferrara D, Moult EM, Fujimoto JG, Abu-Qamar O, Duker JS, et al. FULL-THICKNESS MACULAR HOLE SIZE BY HYPERTRANSMISSION SIGNAL ON SPECTRAL-DOMAIN OPTICAL COHERENCE TOMOGRAPHY. Retina. 2021;41:2059\u201365.","journal-title":"Retina"},{"key":"7878_CR95","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40942-024-00573-1","volume":"10","author":"M Hanai","year":"2024","unstructured":"Hanai M, Amaral DC, Jacometti R, Aguiar EHC, Gomes FC, Cyrino LG, et al. Large macular hole and autologous retinal transplantation: a systematic review and meta-analysis. Int J Retina Vitreous. 2024;10:56.","journal-title":"Int J Retina Vitreous"},{"key":"7878_CR96","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000323910","volume":"46","author":"W Xuqian","year":"2011","unstructured":"Xuqian W, Kanghua L, WeiHong Y, Xi Y, Rongping D, Qin H, et al. Intraocular transplantation of human adipose-derived mesenchymal stem cells in a rabbit model of experimental retinal holes. Ophthalmic Res. 2011;46:199\u2013207.","journal-title":"Ophthalmic Res"},{"key":"7878_CR97","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1007\/s00417-018-4097-3","volume":"256","author":"X Zhang","year":"2018","unstructured":"Zhang X, Liu J, Yu B, Ma F, Ren X, Li X. Effects of mesenchymal stem cells and their exosomes on the healing of large and refractory macular holes. Graefes Arch Clin Exp Ophthalmol. 2018;256:2041\u201352.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"7878_CR98","doi-asserted-by":"crossref","unstructured":"Nuzzi R, Tridico F. Perspectives of autologous mesenchymal stem-cell transplantation in macular hole surgery: a review of current findings. J Ophthalmol. 2019, 2019: 3162478.","DOI":"10.1155\/2019\/3162478"},{"key":"7878_CR99","doi-asserted-by":"crossref","unstructured":"Chang Y-F, Cheng Y-H, Ko Y-C, Chiou S-H, Liu CJ-L. Anti-apoptotic and autophagic effect: using conditioned medium from human bone marrow mesenchymal stem cells to treat human trabecular meshwork cells. Regen Ther. 2023;22:50\u201358.","DOI":"10.1016\/j.reth.2022.12.002"},{"key":"7878_CR100","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s13287-019-1362-2","volume":"10","author":"Y Qi","year":"2019","unstructured":"Qi Y, Ma J, Li S, Liu W. Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes. Stem Cell Res Ther. 2019;10:274.","journal-title":"Stem Cell Res Ther"},{"key":"7878_CR101","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/ar4677","volume":"16","author":"TG Woodworth","year":"2014","unstructured":"Woodworth TG, Furst DE. Safety and feasibility of umbilical cord mesenchymal stem cells in treatment-refractory systemic lupus erythematosus nephritis: time for a double-blind placebo-controlled trial to determine efficacy. Arthritis Res Ther. 2014;16:113.","journal-title":"Arthritis Res Ther"},{"key":"7878_CR102","doi-asserted-by":"crossref","first-page":"107899","DOI":"10.1016\/j.exer.2019.107899","volume":"191","author":"M Ma","year":"2020","unstructured":"Ma M, Li B, Zhang M, Zhou L, Yang F, Ma F, et al. Therapeutic effects of mesenchymal stem cell-derived exosomes on retinal detachment. Exp Eye Res. 2020;191:107899.","journal-title":"Exp Eye Res"},{"key":"7878_CR103","doi-asserted-by":"crossref","first-page":"9181","DOI":"10.2147\/IJN.S278687","volume":"15","author":"M-R Wu","year":"2020","unstructured":"Wu M-R, Lee C-H, Hsiao J-K. Bidirectional enhancement of cell proliferation between iron oxide nanoparticle-labeled mesenchymal stem cells and choroid plexus in a cell-based therapy model of ischemic stroke. Int J Nanomed. 2020;15:9181\u201395.","journal-title":"Int J Nanomed"},{"key":"7878_CR104","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3341\/kjo.2011.25.4.268","volume":"25","author":"JK Chung","year":"2011","unstructured":"Chung JK, Park TK, Ohn YH, Park SK, Hong DS. Modulation of retinal wound healing by systemically administered bone marrow-derived mesenchymal stem cells. Korean J Ophthalmol. 2011;25:268\u201374.","journal-title":"Korean J Ophthalmol"},{"key":"7878_CR105","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1038\/s41551-023-01112-3","volume":"8","author":"H Bao","year":"2024","unstructured":"Bao H, Tian Y, Wang H, Ye T, Wang S, Zhao J, et al. Exosome-loaded degradable polymeric microcapsules for the treatment of vitreoretinal diseases. Nat Biomed Eng. 2024;8:1436\u201352.","journal-title":"Nat Biomed Eng"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07878-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T15:47:03Z","timestamp":1774972023000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07878-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":105,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7878"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07878-9","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"4 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have not use AI-generated work in this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Consent for publication from participants is not applicable for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"448"}}